Economic recession and global mettle down have brought the question of insurance

company investment to the forefront. Growing attention has shifted to the pattern of investments by the

insurance and question of how to evaluate such investments. The aim of this research is to evaluate

investment compositions which are made by life insurance companies in Indonesia, as well as to know the

effects on the performance of Insurance companies

Amann, A

Antus, B

Baraldi, E

Barnes, Pj

Bikov, A

Boots, Aw

Bos, Ld

Brinkman, P

Bucca, C

Carpagnano, Ge

Corradi, M

Cristescu, S

de Jongste, Jc

Dinh-Xuan, At

Dompeling, E

Fens, N

Fowler, S

Hogman, M

Hohlfeld, Jm

Holz, O

Horvath, I

Jobsis, Q

Knobel, Hh

Kostikas, K

Lehtimaki, L

Loukides, S

Lundberg, J

Montuschi, P (ORCID:0000-0001-5589-1750)

Olin, Ac

Pennazza, G

Reinhold, P

Ricciardolo, Flm

Rosias, P

Santonico, M

Spanevello, A

Sterk, Pj

Tonia, T

Van De Kant, Kv

van der Schee, Mp

Van Muylem, A

van Schooten, Fj

Vink, Tj

Breath tests cover the fraction of nitric oxide in expired gas (FeNO), volatile organic compounds (VOCs), variables in exhaled breath condensate (EBC) and other measurements. For EBC and for FeNO, official recommendations for standardised procedures are more than 10 years old and there is none for exhaled VOCs and particles. The aim of this document is to provide technical standards and recommendations for sample collection and analytic approaches and to highlight future research priorities in the field. For EBC and FeNO, new developments and advances in technology have been evaluated in the current document. This report is not intended to provide clinical guidance on disease diagnosis and management.

Clinicians and researchers with expertise in exhaled biomarkers were invited to participate. Published studies regarding methodology of breath tests were selected, discussed and evaluated in a consensus-based manner by the Task Force members.

Recommendations for standardisation of sampling, analysing and reporting of data and suggestions for research to cover gaps in the evidence have been created and summarised.

Application of breath biomarker measurement in a standardised manner will provide comparable results, thereby facilitating the potential use of these biomarkers in clinical practice

Horváth, I.

Barnes, P. J.

Loukides, S.

Sterk, P. J.

Högman, M.

Olin, A. C.

Amann, A.

Antus, B.

Baraldi, E.

Bikov, A.

Boots, A. W.

Bos, L. D.

Brinkman, P.

Bucca, C.

Carpagnano. G. E.

Corradi, M.

Cristescu S,

de Jongste, J. C.

Dinh-Xuan, A. T.

Dompeling, E.

Fens, N.

Fowler, S.

Hohlfeld, J. M.

Holz, O.

Jöbsis, Q.

Van De Kant, K.

Knobel, H. H.

Kostikas, K.

Lehtimäki, L.

Lundberg, J.

Montuschi, P.

Van Muylem, A.

Pennazza, G.

Reinhold, Petra

Ricciardolo, F. L. M.

Rosias, P.

Santonico, M.

van der Schee, M. P.

van Schooten, F. J.

Spanevello, A.

Tonia, T,.

Vink, T. J.

OA OpenAgrar repository

A European Respiratory Society technical standard: exhaled biomarkers in lung disease

Suhendra, Euphrasia Susy

Gunadarma University Repository

ANALYSIS OF LIFE INSURANCE INVESTMENT COMPOSITION

Barnes, PJ

Sterk, PJ

Olin, AC

Boots, AW

Bos, LD

Carpagnano, GE

Jongste, Johan

Dinh-Xuan, AT

Hohlfeld, JM

Van De Kant, KV

Knobel, HH

Montuschi, P

Ricciardolo, FLM

van der Schee, MP

van Schooten, FJ

Vink, TJ

EUR Research Repository

Breath tests cover the fraction of nitric oxide in expired gas (FeNO), volatile organic compounds (VOCs), variables in exhaled breath condensate (EBC) and other measurements. For EBC and for FeNO, official recommendations for standardised procedures are more than 10 years old and there is none for exhaled VOCs and particles. The aim of this document is to provide technical standards and recommendations for sample collection and analytic approaches and to highlight future research priorities in the field. For EBC and FeNO, new developments and advances in technology have been evaluated in the current document. This report is not intended to provide clinical guidance on disease diagnosis and management. Clinicians and researchers with expertise in exhaled biomarkers were invited to participate. Published studies regarding methodology of breath tests were selected, discussed and evaluated in a consensus-based manner by the Task Force members. Recommendations for standardisation of sampling, analysing and reporting of data and suggestions for research to cover gaps in the evidence have been created and summarised. Application of breath biomarker measurement in a standardised manner will provide comparable results, thereby facilitating the potential use of these biomarkers in clinical practice

Horvath, I.

Hogman, M.

Olin, Anna-Carin,

Carpagnano, G. E.

Cristescu, S.

Jobsis, Q.

Van De Kant, K. V.

Lehtimaki, L.

Reinhold, P.

Tonia, T.

Swepub

NARCIS 

Breath tests cover the fraction of nitric oxide in expired gas (FeNO), volatile organic compounds (VOCs), variables in exhaled breath condensate (EBC) and other measurements. For EBC and for FeNO, official recommendations for standardised procedures are more than 10 years old and there is none for exhaled VOCs and particles. The aim of this document is to provide technical standards and recommendations for sample collection and analytic approaches and to highlight future research priorities in the field. For EBC and FeNO, new developments and advances in technology have been evaluated in the current document. This report is not intended to provide clinical guidance on disease diagnosis and management.Clinicians and researchers with expertise in exhaled biomarkers were invited to participate. Published studies regarding methodology of breath tests were selected, discussed and evaluated in a consensus-based manner by the Task Force members.Recommendations for standardisation of sampling, analysing and reporting of data and suggestions for research to cover gaps in the evidence have been created and summarised.Application of breath biomarker measurement in a standardised manner will provide comparable results, thereby facilitating the potential use of these biomarkers in clinical practice

PubliCatt

ANALYSIS OF LIFE INSURANCE INVESTMENT COMPOSITION

Abstract

Similar works

Full text

Available Versions

OA OpenAgrar repository

Gunadarma University Repository

EUR Research Repository

Swepub

EUR Research Repository

NARCIS

PubliCatt